Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,951 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for younger patients with acute myeloid leukemia: a registry-based study.
Yanada M, Kurosawa S, Kobayashi T, Ozawa Y, Kanamori H, Kobayashi N, Sawa M, Nakamae H, Uchida N, Hashimoto H, Fukuda T, Hirokawa M, Atsuta Y, Yano S. Yanada M, et al. Among authors: kobayashi n, kobayashi t. Bone Marrow Transplant. 2017 Jun;52(6):818-824. doi: 10.1038/bmt.2016.358. Epub 2017 Jan 23. Bone Marrow Transplant. 2017. PMID: 28112749 Clinical Trial.
Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML-87 Study of the Japan Adult Leukemia Study Group.
Ohno R, Kobayashi T, Tanimoto M, Hiraoka A, Imai K, Asou N, Tomonaga M, Tsubaki K, Takahashi I, Kodera Y, et al. Ohno R, et al. Among authors: kobayashi t. Cancer. 1993 Jun 15;71(12):3888-95. doi: 10.1002/1097-0142(19930615)71:12<3888::aid-cncr2820711216>3.0.co;2-g. Cancer. 1993. PMID: 8508355 Clinical Trial.
[EPOCH therapy for relapsed/refractory lymphoid malignancies].
Dobashi N, Usui N, Kobayashi T, Yamazaki H, Asai O, Yano S, Kato A, Watanabe H, Nagamine M, Katori M, Tajima N, Kuraishi Y. Dobashi N, et al. Among authors: kobayashi t. Rinsho Ketsueki. 1998 Apr;39(4):267-72. Rinsho Ketsueki. 1998. PMID: 9597893 Clinical Trial. Japanese.
Role of daunorubicin in the induction therapy for adult acute myeloid leukemia.
Usui N, Dobashi N, Kobayashi T, Yano S, Maki N, Asai O, Saito T, Yamaguchi Y, Watanabe H, Kato A, Ogihara A, Katori M, Nagamine M, Takei Y, Yamazaki H, Funakoshi S, Tajima N, Ogawa M, Kuraishi Y. Usui N, et al. Among authors: kobayashi t. J Clin Oncol. 1998 Jun;16(6):2086-92. doi: 10.1200/JCO.1998.16.6.2086. J Clin Oncol. 1998. PMID: 9626208 Clinical Trial.
[Prognostic significance of CD7 expression in adult acute myeloid leukemia].
Saito T, Usui N, Dobashi N, Maki N, Asai O, Yano S, Kato A, Watanabe H, Katori M, Nagamine M, Ogihara A, Yamazaki H, Kobayashi T, Tajima N, Kuraishi Y. Saito T, et al. Among authors: kobayashi t. Rinsho Ketsueki. 1998 Jul;39(7):481-6. Rinsho Ketsueki. 1998. PMID: 9750454 Japanese.
[The role of daunorubicin in induction therapy for adult acute myeloid leukemia].
Usui N, Dobashi N, Asai O, Yano S, Kato A, Osawa H, Uno S, Katori M, Nagamine M, Yahagi Y, Yamaguchi Y, Saito T, Kasama K, Takei Y, Ogihara A, Yamazaki H, Kobayashi T, Tajima N, Ogawa M, Kuraishi Y. Usui N, et al. Among authors: kobayashi t. Gan To Kagaku Ryoho. 2000 Jul;27(8):1152-9. Gan To Kagaku Ryoho. 2000. PMID: 10945010 Clinical Trial. Japanese.
[Indication of allogeneic bone marrow transplantation (BMT) from HLA identical sibling in adult acute myeloblastic leukemia--comparative study of BMT and chemotherapy in patients with the first remission state. Nagoya BMT Group. Japan Adult Leukemia Study Group].
Morishima Y, Tanimoto M, Kodera Y, Miyawaki S, Hirabayashi N, Tomonaga M, Kojima H, Kobayashi T, Onozawa Y, Nitta M, et al. Morishima Y, et al. Among authors: kobayashi t. Rinsho Ketsueki. 1995 Jun;36(6):517-23. Rinsho Ketsueki. 1995. PMID: 7643444 Clinical Trial. Japanese.
14,951 results
You have reached the last available page of results. Please see the User Guide for more information.